Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2%;Intérêt et limite de la greffe multiple (troisime kératoplastie) sous ciclosporine locale 2 %

Journal Francais d'Ophtalmologie

Volumn 33, Issue 10, 2010, Pages 710-714

  Alalwani, H ^a   Omer Saleh, B ^a   Rocher, N ^a   Renard, G ^a   Bourges, J L ^a   Legeais, J M ^a  

^a HÔTEL DIEU   (France)

Author keywords

Corneal graft; Cyclosporin A; Rejection

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CORNEA TRANSPLANTATION; FEMALE; GRAFT REJECTION; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; CORNEAL TRANSPLANTATION; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78649913008     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2010.09.019     Document Type: Article

References (32)

1. K.A. Williams, D. Roder, A. Esterman, S.M. Muehlberg, and D.J. Coster Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry Ophthalmology 99 1992 403 414
2. V.M. Borderie, P.Y. Boëlle, O. Touzeau, C. Allouch, S. Boutboul, and L. Laroche Predicted long-term outcome of corneal transplantation Ophthalmology 116 2009 2354 2360
3. A. Maeno, J. Naor, H.M. Lee, W.S. Hunter, and D.S. Rootman Three decades of corneal transplantation: indications and patient characteristics Cornea 19 2000 7 11
4. P.Y. Koay, W.H. Lee, and F.C. Figueiredo Opinions on risk factors and management of corneal graft rejection in the United Kingdom Cornea 24 2005 292 296
5. M.G. Maguire, W.J. Stark, J.D. Gottsch, R.D. Stulting, A. Sugar, and N.E. Fink Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group Ophthalmology 101 1994 1536 1547
6. V. Bersudsky, T. Blum-Hareuveni, U. Rehany, and S. Rumelt The profile of repeated corneal transplantation Ophthalmology 108 2001 461 469
7. H.D. Perry, E.D. Donnenfeld, A.J. Kanellopoulos, and G.A. Grossman Topical cyclosporin A in the management of postkeratoplasty glaucoma Cornea 16 1997 284 288
8. K.A. Williams, S.A. Erickson, and D.J. Coster Topical steroid, cyclosporin A, and the outcome of rat corneal allografts Br J Ophthalmol 71 1987 239 242
9. C.S. Bouchard, and H.D. Cavanagh The high-risk keratoplasty patient-quo vadis? Cornea 13 1994 1 3
10. S. Rumelt, V. Bersudsky, T. Blum-Hareuveni, and U. Rehany Systemic cyclosprin A in high failure risk, repeated corneal transplantation Br J Ophthalmol 86 2002 988 992
11. J.K. Milani, U. Pleyer, A. Dukes, H.J. Chou, S. Lutz, and D. Rückert Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye Ophthalmology 100 1993 890 896
12. J.L. Bourges, F. Lallemand, E. Agla, K. Besseghir, J.M. Dumont, and D. BenEzra Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rat Mol Vis 12 2006 1461 1466
13. C.G. Orosz, R.K. Fidelus, D.C. Roopenian, M.B. Widmer, R.M. Ferguson, and F.H. Bach Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A J Immunol 138 1987 1115 1120
14. P.-Y. Robert, V. Leconte, C. Olivé, V. Ratsimbazafy, M. Javerliat, and J.-P. Adenis Collyre la cyclosporine A : fabrication, toxicité, pharmacocinétique et indications en l'an 2000 J Fr Ophtalmol 5 2001 527
15. F. Chast, F. Lemare, J.M. Legeais, R. Batista, C. Bardin, and G. Renard Cyclosporine 2% eye drops preparation J Fr Ophtalmol 27 2004 567 576
16. A.C. Poon, J.E. Forbes, J.K. Dart, S. Subramaniam, C. Bunce, and P. Madison Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study Br J Ophthalmol 85 2001 1464 1469
17. K. Inoue, C. Kimura, S. Amano, T. Sato, N. Fujita, and F. Kagaya Long-term outcome of systemic cyclosporin treatment following penetrating keratoplasty Jpn J Ophthalmol 45 2001 378 382
18. J.B. Ranndleman, and R.D. Stulting Prevention and treatment of corneal graft rejection: current practice patterns (2004) Cornea 25 2006 286 290
19. J.C. Hill The use of systemic cyclosporine in human corneal transplantation: a preliminary report Documenta Ophthalmol 62 1986 337 344
20. L. Goichot-Bonnat, P. Chemla, and Y. Pouliquen Cyclosporine-A collyre dans la prévention du rejet de greffe de cornée haut risque J Fr Ophtalmol 10 1987 213 216
21. K. Miller, C. Huber, D. Niederwieser, and W. Göttinger Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporin Transplantation 45 1988 651 653
22. D.D. Tang-Liu, and A. Acheampong Ocular pharmacokinetics and safety of ciclosporin. A novel topical treatment for dry eye Clin Pharmacokinet 44 2005 247 261
23. M. Diaz-llopis, and J.L Menezo Penetration of ciclosporin 2% eyedrops into human aqueous humour Br J Ophthalmol 73 1989 600 603
24. D. BenEzra, G. Maftzir, C. de Courten, and P. Timonen Ocular penetration of cyclosporin A. III: The human eye Br J Ophthalmol 74 1990 350 352 (Pubitemid 20191167)
25. M.O. Price, and FW Price Jr Efficacy of topical cyclosporine 0.05%for prevention of cornea transplant rejection episodes Ophthalmology 113 2006 1785 1790
26. M. Unal, and I. Yücel Evaluation of topical cyclosporine 0.05% for prevention of rejection in high risk corneal grafts Br J Ophthalmol 92 2008 1411
27. H.D. Perry, and E.D. Donnenfeld Topical 0.05% cyclosporine in the treatment of dry eye Expert Opin Pharmacother 5 2004 2099 2107
28. C.B. Cosar, P.R. Laibson, E.J. Cohen, and C.J. Rapuano Topical cyclosporin in pediatric keratoplasty Eye Contact Lens 29 2003 103 107
29. F. Hoffmann, and M. Wiederholt Lokale behandlung des hornhaut transplantes beim menscheu mit cyclosporin A Klin Monatsbl Augenheilkd 187 1985 92 96
30. M.W. Belin, C.S. Bouchard, S. Frantz, and J. Chmielinska Topical cyclosporine in high-risk corneal transplants Ophthalmology 96 1989 1144 1150
31. K. Inoue, S. Amano, C. Kimura, T. Sato, N. Fujita, and F. Kagaya Long-term effects of topical cyclosporin A treatment after penetrating keratoplasty Jpn J Ophthalmol 44 2000 302 305
32. Bourges JL, Dighiero P, Elie C, Gicquel JJ, Villela F, Agla EK, et al. A three-year follow-up in topical cyclosporine treatment for high-risk penetrating keratoplasty: tolerance and graft outcome. American Academy of Ophthalmology 2006; Annual Meeting (Las Vegas): PO090.